• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌病发病机制概念的前沿进展

Advanced Evolution of Pathogenesis Concepts in Cardiomyopathies.

作者信息

Li Chia-Jung, Chen Chien-Sheng, Yiang Giou-Teng, Tsai Andy Po-Yi, Liao Wan-Ting, Wu Meng-Yu

机构信息

Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan.

Department of Emergency Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei 231, Taiwan.

出版信息

J Clin Med. 2019 Apr 16;8(4):520. doi: 10.3390/jcm8040520.

DOI:10.3390/jcm8040520
PMID:30995779
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6518034/
Abstract

Cardiomyopathy is a group of heterogeneous cardiac diseases that impair systolic and diastolic function, and can induce chronic heart failure and sudden cardiac death. Cardiomyopathy is prevalent in the general population, with high morbidity and mortality rates, and contributes to nearly 20% of sudden cardiac deaths in younger individuals. Genetic mutations associated with cardiomyopathy play a key role in disease formation, especially the mutation of sarcomere encoding genes and ATP kinase genes, such as titin, lamin A/C, myosin heavy chain 7, and troponin T1. Pathogenesis of cardiomyopathy occurs by multiple complex steps involving several pathways, including the Ras-Raf-mitogen-activated protein kinase-extracellular signal-activated kinase pathway, G-protein signaling, mechanotransduction pathway, and protein kinase B/phosphoinositide 3-kinase signaling. Excess biomechanical stress induces apoptosis signaling in cardiomyocytes, leading to cell loss, which can induce myocardial fibrosis and remodeling. The clinical features and pathophysiology of cardiomyopathy are discussed. Although several basic and clinical studies have investigated the mechanism of cardiomyopathy, the detailed pathophysiology remains unclear. This review summarizes current concepts and focuses on the molecular mechanisms of cardiomyopathy, especially in the signaling from mutation to clinical phenotype, with the aim of informing the development of therapeutic interventions.

摘要

心肌病是一组异质性心脏疾病,会损害心脏的收缩和舒张功能,并可导致慢性心力衰竭和心源性猝死。心肌病在普通人群中普遍存在,发病率和死亡率都很高,在年轻个体的心源性猝死中占近20%。与心肌病相关的基因突变在疾病形成中起关键作用,尤其是肌节编码基因和ATP激酶基因的突变,如肌联蛋白、核纤层蛋白A/C、肌球蛋白重链7和肌钙蛋白T1。心肌病的发病机制通过涉及多个途径的多个复杂步骤发生,包括Ras-Raf-丝裂原活化蛋白激酶-细胞外信号调节激酶途径、G蛋白信号传导、机械转导途径和蛋白激酶B/磷脂酰肌醇3激酶信号传导。过度的生物力学应激会诱导心肌细胞凋亡信号,导致细胞丢失,进而可诱导心肌纤维化和重塑。本文讨论了心肌病的临床特征和病理生理学。尽管一些基础研究和临床研究已经对心肌病的机制进行了调查,但详细的病理生理学仍不清楚。本综述总结了当前的概念,并重点关注心肌病的分子机制,特别是从突变到临床表型的信号传导,旨在为治疗干预措施的开发提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16bb/6518034/14ad7c6c12da/jcm-08-00520-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16bb/6518034/ccda71a0a6cd/jcm-08-00520-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16bb/6518034/14ad7c6c12da/jcm-08-00520-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16bb/6518034/ccda71a0a6cd/jcm-08-00520-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16bb/6518034/14ad7c6c12da/jcm-08-00520-g002.jpg

相似文献

1
Advanced Evolution of Pathogenesis Concepts in Cardiomyopathies.心肌病发病机制概念的前沿进展
J Clin Med. 2019 Apr 16;8(4):520. doi: 10.3390/jcm8040520.
2
Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.通过使用Ion Torrent PGM系统的靶向测序方法,在遗传性心肌病患者中鉴定包括双突变在内的新型突变。
Int J Mol Med. 2016 Jun;37(6):1511-20. doi: 10.3892/ijmm.2016.2565. Epub 2016 Apr 14.
3
DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.DNA 损伤反应/TP53 通路被激活并有助于伴有 LMNA(核纤层蛋白 A/C)突变的扩张型心肌病的发病机制。
Circ Res. 2019 Mar 15;124(6):856-873. doi: 10.1161/CIRCRESAHA.118.314238.
4
Hypertrophic cardiomyopathy: genetics and clinical perspectives.肥厚型心肌病:遗传学与临床展望
Cardiovasc Diagn Ther. 2019 Oct;9(Suppl 2):S388-S415. doi: 10.21037/cdt.2019.02.01.
5
The Role of ERK1/2 in the Development of Diabetic Cardiomyopathy.细胞外信号调节激酶1/2(ERK1/2)在糖尿病心肌病发展中的作用
Int J Mol Sci. 2016 Dec 8;17(12):2001. doi: 10.3390/ijms17122001.
6
Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.肥厚型心肌病的发病机制是突变而非疾病特异性:心肌肌钙蛋白T E163R和R92Q小鼠模型的比较
J Am Heart Assoc. 2017 Jul 22;6(7):e005407. doi: 10.1161/JAHA.116.005407.
7
Cardiomyopathy: molecular and immunological aspects (review).心肌病:分子与免疫学方面(综述)
Int J Mol Med. 2003 Jan;11(1):13-6.
8
From the sarcomere to the nucleus: role of genetics and signaling in structural heart disease.从肌节到细胞核:遗传学和信号传导在结构性心脏病中的作用
Annu Rev Genomics Hum Genet. 2000;1:179-223. doi: 10.1146/annurev.genom.1.1.179.
9
Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.肥厚型心肌病:遗传学、发病机制、临床表现、诊断与治疗
Circ Res. 2017 Sep 15;121(7):749-770. doi: 10.1161/CIRCRESAHA.117.311059.
10
Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy.辛伐他汀可使人类肥厚型心肌病转基因兔模型的心肌肥厚和纤维化消退,并改善心脏功能。
Circulation. 2001 Jul 17;104(3):317-24. doi: 10.1161/hc2801.094031.

引用本文的文献

1
Combination of reverse shock index and simplified motor score as a strong discriminator of trauma outcomes.反向休克指数与简化运动评分相结合作为创伤结局的有力判别指标。
Ann Med. 2025 Dec;57(1):2458205. doi: 10.1080/07853890.2025.2458205. Epub 2025 Jan 29.
2
Association Between Diurnal Temperature Range and Risk of Cardiomyopathy-Induced Hospitalisation in Henan, China: A Time-Series Study.中国河南昼夜温差与心肌病导致住院风险之间的关联:一项时间序列研究
Risk Manag Healthc Policy. 2025 Jan 21;18:279-290. doi: 10.2147/RMHP.S502132. eCollection 2025.
3
An hiPSC-CM approach for electrophysiological phenotyping of a patient-specific case of short-coupled TdP.

本文引用的文献

1
Altered force generation and cell-to-cell contractile imbalance in hypertrophic cardiomyopathy.肥厚型心肌病中力生成的改变和细胞间收缩失衡。
Pflugers Arch. 2019 May;471(5):719-733. doi: 10.1007/s00424-019-02260-9. Epub 2019 Feb 11.
2
Hereditary heart disease: pathophysiology, clinical presentation, and animal models of HCM, RCM, and DCM associated with mutations in cardiac myosin light chains.遗传性心脏病:心肌肌球蛋白轻链突变相关的肥厚型心肌病、限制型心肌病和扩张型心肌病的病理生理学、临床表现和动物模型。
Pflugers Arch. 2019 May;471(5):683-699. doi: 10.1007/s00424-019-02257-4. Epub 2019 Jan 31.
3
Arrhythmic Genotypes in Familial Dilated Cardiomyopathy: Implications for Genetic Testing and Clinical Management.
一种用于短联律间期尖端扭转型室速患者特异性病例电生理表型分析的人诱导多能干细胞衍生心肌细胞方法。
Stem Cell Res Ther. 2024 Dec 18;15(1):470. doi: 10.1186/s13287-024-04074-8.
4
The Emerging Role of Epigenetics in Therapeutic Targeting of Cardiomyopathies.表观遗传学在心肌病治疗靶点中的新兴作用。
Int J Mol Sci. 2021 Aug 13;22(16):8721. doi: 10.3390/ijms22168721.
5
Clinical Insights Into Heritable Cardiomyopathies.遗传性心肌病的临床见解
Front Genet. 2021 Apr 28;12:663450. doi: 10.3389/fgene.2021.663450. eCollection 2021.
6
Genetic Restrictive Cardiomyopathy: Causes and Consequences-An Integrative Approach.遗传性限制型心肌病:病因与后果——综合分析方法
Int J Mol Sci. 2021 Jan 8;22(2):558. doi: 10.3390/ijms22020558.
7
Phosphoinositide Signaling and Mechanotransduction in Cardiovascular Biology and Disease.心血管生物学与疾病中的磷酸肌醇信号传导和机械转导
Front Cell Dev Biol. 2020 Dec 14;8:595849. doi: 10.3389/fcell.2020.595849. eCollection 2020.
8
Effects of Individual and Coexisting Diabetes and Cardiomyopathy on Diastolic Function in Rats ().个体和共存的糖尿病与心肌病对大鼠舒张功能的影响()。
Comp Med. 2020 Dec 1;70(6):499-509. doi: 10.30802/AALAS-CM-20-000042. Epub 2020 Nov 2.
9
Strategies for targeting the cardiac sarcomere: avenues for novel drug discovery.靶向心肌肌节的策略:新型药物发现的途径。
Expert Opin Drug Discov. 2020 Apr;15(4):457-469. doi: 10.1080/17460441.2020.1722637. Epub 2020 Feb 18.
10
Hydrogen Sulfide as a Potential Alternative for the Treatment of Myocardial Fibrosis.硫化氢作为心肌纤维化治疗的一种潜在替代方法。
Oxid Med Cell Longev. 2020 Jan 23;2020:4105382. doi: 10.1155/2020/4105382. eCollection 2020.
家族性扩张型心肌病中的心律失常基因型:对基因检测和临床管理的影响。
Heart Lung Circ. 2019 Jan;28(1):31-38. doi: 10.1016/j.hlc.2018.09.010. Epub 2018 Oct 11.
4
Left Ventricular Hypertrophy in Athletes: Differentiating Physiology From Pathology.运动员的左心室肥厚:区分生理状态与病理状态
Curr Treat Options Cardiovasc Med. 2018 Oct 26;20(12):96. doi: 10.1007/s11936-018-0691-2.
5
Genetics of Dilated Cardiomyopathy.扩张型心肌病的遗传学。
Curr Cardiol Rep. 2018 Sep 27;20(11):121. doi: 10.1007/s11886-018-1061-0.
6
Cardiomyopathies and Related Changes in Contractility of Human Heart Muscle.心肌病和人心肌收缩力的相关变化。
Int J Mol Sci. 2018 Jul 31;19(8):2234. doi: 10.3390/ijms19082234.
7
Actin-associated proteins and cardiomyopathy-the 'unknown' beyond troponin and tropomyosin.肌动蛋白相关蛋白与心肌病——肌钙蛋白和原肌球蛋白之外的“未知因素”
Biophys Rev. 2018 Aug;10(4):1121-1128. doi: 10.1007/s12551-018-0428-1. Epub 2018 Jun 5.
8
Prevalence of clinically apparent hypertrophic cardiomyopathy in Germany-An analysis of over 5 million patients.德国临床明显肥厚型心肌病的患病率:一项超过 500 万患者的分析。
PLoS One. 2018 May 3;13(5):e0196612. doi: 10.1371/journal.pone.0196612. eCollection 2018.
9
Current Mechanistic Concepts in Ischemia and Reperfusion Injury.缺血再灌注损伤的当前机制概念
Cell Physiol Biochem. 2018;46(4):1650-1667. doi: 10.1159/000489241. Epub 2018 Apr 20.
10
Management of systolic anterior motion of the mitral valve: a mechanism-based approach.二尖瓣收缩期前向运动的管理:一种基于机制的方法。
Gen Thorac Cardiovasc Surg. 2018 Jul;66(7):379-389. doi: 10.1007/s11748-018-0915-0. Epub 2018 Apr 3.